DE69422818T2 - Neue emulsionsformulierung - Google Patents

Neue emulsionsformulierung

Info

Publication number
DE69422818T2
DE69422818T2 DE69422818T DE69422818T DE69422818T2 DE 69422818 T2 DE69422818 T2 DE 69422818T2 DE 69422818 T DE69422818 T DE 69422818T DE 69422818 T DE69422818 T DE 69422818T DE 69422818 T2 DE69422818 T2 DE 69422818T2
Authority
DE
Germany
Prior art keywords
pct
formulation
sec
optionally
date
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69422818T
Other languages
English (en)
Other versions
DE69422818D1 (de
Inventor
Stefan Lundquist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB filed Critical Astra AB
Application granted granted Critical
Publication of DE69422818D1 publication Critical patent/DE69422818D1/de
Publication of DE69422818T2 publication Critical patent/DE69422818T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
DE69422818T 1993-10-07 1994-10-05 Neue emulsionsformulierung Expired - Lifetime DE69422818T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9303281A SE9303281D0 (sv) 1993-10-07 1993-10-07 New formulation
PCT/SE1994/000926 WO1995009609A1 (en) 1993-10-07 1994-10-05 New emulsion formulation

Publications (2)

Publication Number Publication Date
DE69422818D1 DE69422818D1 (de) 2000-03-02
DE69422818T2 true DE69422818T2 (de) 2000-07-27

Family

ID=20391342

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69422818T Expired - Lifetime DE69422818T2 (de) 1993-10-07 1994-10-05 Neue emulsionsformulierung

Country Status (31)

Country Link
US (2) US5843465A (de)
EP (1) EP0722316B1 (de)
JP (1) JPH09504279A (de)
CN (1) CN1134663A (de)
AT (1) ATE189119T1 (de)
AU (1) AU701512B2 (de)
BR (1) BR9407748A (de)
CA (1) CA2172143A1 (de)
CZ (1) CZ94396A3 (de)
DE (1) DE69422818T2 (de)
DK (1) DK0722316T3 (de)
EE (1) EE03235B1 (de)
EG (1) EG20540A (de)
ES (1) ES2145158T3 (de)
FI (1) FI961525A (de)
GR (1) GR3033255T3 (de)
HK (1) HK1009257A1 (de)
HU (1) HUT74638A (de)
IL (1) IL111131A (de)
IS (1) IS4209A (de)
MA (1) MA23344A1 (de)
NO (1) NO961363D0 (de)
NZ (1) NZ274583A (de)
PL (1) PL313767A1 (de)
PT (1) PT722316E (de)
SE (1) SE9303281D0 (de)
SG (1) SG47896A1 (de)
SK (1) SK39396A3 (de)
TN (1) TNSN94099A1 (de)
WO (1) WO1995009609A1 (de)
ZA (1) ZA947351B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US6281175B1 (en) 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
US6054421A (en) * 1997-09-23 2000-04-25 Scimed Life Systems, Inc. Medical emulsion lubricant
US20020086857A1 (en) * 2000-09-15 2002-07-04 Mcdonald George B. Method of long-term treatment of graft-versus-host disease using topical active corticosterioids
US20100184732A1 (en) * 2000-09-15 2010-07-22 Mcdonald George Method of long-term treatment of graft-versus-host disease using topical active corticosteroids
DE10059430A1 (de) * 2000-11-30 2002-06-06 Cognis Deutschland Gmbh Feinteilige Emulsionen
EP1401396A4 (de) 2001-06-15 2009-08-05 Cornerstone Pharmaceuticals Pharmazeutische und diagnostische zusammensetzungen mit nanopartikeln für die behandlung von zielgeweben und zellen
ATE365537T1 (de) * 2001-08-06 2007-07-15 Astrazeneca Ab Wässrige dispersion stabiler nanopartikel eines wasserunlöslichen wirkstoffs und ein hilfsstoff wie mittelkettige triglyceride (mct)
TWI248159B (en) * 2002-01-25 2006-01-21 Nanya Technology Corp Manufacturing method for shallow trench isolation with high aspect ratio
GB0216700D0 (en) * 2002-07-18 2002-08-28 Astrazeneca Ab Process
US7544674B2 (en) 2002-10-25 2009-06-09 Galderma S.A. Topical skin care composition
US8685428B2 (en) * 2002-12-10 2014-04-01 Advanced Cardiovascular Systems, Inc. Therapeutic composition and a method of coating implantable medical devices
GB0230087D0 (en) * 2002-12-24 2003-01-29 Astrazeneca Ab Therapeutic agents
GB0230088D0 (en) * 2002-12-24 2003-01-29 Astrazeneca Ab Therapeutic agents
GB0302673D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
GB0302672D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
GB0302671D0 (en) * 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
US7323206B1 (en) 2003-03-04 2008-01-29 B. Braun Medical Inc. Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
EP1641779A1 (de) * 2003-06-18 2006-04-05 AstraZeneca AB 2-substituierte 5, 6-diaryl-pyrazinderivative als cb1 modulator
GB0314057D0 (en) * 2003-06-18 2003-07-23 Astrazeneca Ab Therapeutic agents
GB0314261D0 (en) * 2003-06-19 2003-07-23 Astrazeneca Ab Therapeutic agents
US20070140999A1 (en) * 2003-07-18 2007-06-21 Hill Dermaceuticals, Inc. Topical skin care composition containing refined peanut oil
WO2005009406A1 (en) * 2003-07-18 2005-02-03 Hill Dermaceuticals, Inc. Topical skin care composition containing refined peanut oil
US20060099173A1 (en) * 2003-10-24 2006-05-11 Nancy Puglia Topical skin care composition
US20070207107A1 (en) * 2006-03-03 2007-09-06 Gareth Winckle Silicone based emulsions for topical drug delivery
US8473062B2 (en) 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
US9320908B2 (en) 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4073943A (en) * 1974-09-11 1978-02-14 Apoteksvarucentralen Vitrum Ab Method of enhancing the administration of pharmalogically active agents
AT358530B (de) * 1978-04-25 1980-09-10 Plc Pharma Licences Stabilisierungsverfahren
JPS58222014A (ja) * 1982-06-18 1983-12-23 Taisho Pharmaceut Co Ltd プロスタグランジンｅ↓１脂肪乳剤
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic
JPH0818989B2 (ja) * 1984-01-12 1996-02-28 株式会社ミドリ十字 脂肪乳剤中のプロスタグランジンの安定化方法
JPH0647533B2 (ja) * 1984-08-10 1994-06-22 裕 水島 ４−ビフエニリル酢酸系化合物含有脂肪乳剤
US4760096A (en) * 1985-09-27 1988-07-26 Schering Corporation Moisturizing skin preparation
DE3623376A1 (de) * 1986-07-11 1988-01-21 Behringwerke Ag Pharmazeutische formulierung und verfahren zu deren herstellung
GB8919172D0 (en) * 1989-08-23 1989-10-04 Univ Nottingham Useful composition
JP2785981B2 (ja) * 1989-11-20 1998-08-13 株式会社資生堂 乳化組成物
US5089268A (en) * 1990-05-02 1992-02-18 Katz David P Egg phosphatide lipid emulsions altered for a specific therapeutic fatty acid composition

Also Published As

Publication number Publication date
EP0722316B1 (de) 2000-01-26
AU7866794A (en) 1995-05-01
CA2172143A1 (en) 1995-04-13
CN1134663A (zh) 1996-10-30
CZ94396A3 (en) 1996-06-12
MA23344A1 (fr) 1995-07-01
EG20540A (en) 1999-07-31
BR9407748A (pt) 1997-11-11
NZ274583A (en) 1998-01-26
ZA947351B (en) 1995-04-10
EE03235B1 (et) 1999-12-15
SG47896A1 (en) 1998-04-17
NO961363L (no) 1996-04-02
IL111131A (en) 1999-09-22
NO961363D0 (no) 1996-04-02
TNSN94099A1 (fr) 1995-04-25
US5660837A (en) 1997-08-26
FI961525A0 (fi) 1996-04-04
ES2145158T3 (es) 2000-07-01
EP0722316A1 (de) 1996-07-24
HU9600900D0 (en) 1996-05-28
SK39396A3 (en) 1997-02-05
ATE189119T1 (de) 2000-02-15
GR3033255T3 (en) 2000-09-29
JPH09504279A (ja) 1997-04-28
DE69422818D1 (de) 2000-03-02
FI961525A (fi) 1996-04-04
IL111131A0 (en) 1994-12-29
DK0722316T3 (da) 2000-06-13
IS4209A (is) 1995-04-08
PL313767A1 (en) 1996-07-22
PT722316E (pt) 2000-06-30
AU701512B2 (en) 1999-01-28
SE9303281D0 (sv) 1993-10-07
HUT74638A (en) 1997-01-28
HK1009257A1 (en) 1999-05-28
WO1995009609A1 (en) 1995-04-13
US5843465A (en) 1998-12-01

Similar Documents

Publication Publication Date Title
DE69422818D1 (de) Neue emulsionsformulierung
ATE213940T1 (de) Parenteral anzuwendende arzneizubereitung enthaltend amiodaron
DK0850046T3 (da) Mikroemulsioner til anvendelse som vhikel til indgift af active forbindelser
ATE213158T1 (de) Pharmazeutische emulsion
YU2494A (sh) Farmaceutska formulacija za tretiranje zavisnosti od nikotina
SE9402880D0 (sv) New peptide derivatives
ATE153342T1 (de) Adenosinderivate, verfahren zu deren herstellung und pharmazeutische mittel
PT706395E (pt) Uso de ropivacaina na preparacao duma composicao farmaceutica com efeito analgesico e bloqueio motor minimo
SE9502219D0 (sv) Novel medical use
KR880004810A (ko) 소화성 궤양 치료제
DE69215085D1 (de) Aminoacylderivate von gem-diphosphonsauren,verfahren zu deren herstellung und pharmazeutische zubereitungen,die sie enthalten
ATE221068T1 (de) Anellierte beta-carboline

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: GROSSE, BOCKHORNI, SCHUMACHER, 45133 ESSEN